NYSE ARCA | ETF
The fund will seek to achieve its objectives by (1) investing in common stocks of equity securities that pay dividends and (2) writing (i.e., selling) covered call options on a substantial portion of its portfolio of securities.
Under normal market conditions, the fund will invest at least 80% of its net assets (including any borrowings for investment purposes) in equity securities of companies, including other investment companies.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MDT | Medtronic PLC | Healthcare | Medical Devices | 4.31% |
| ADBE | Adobe Systems Incorporated | Technology | Software - Application | 4.16% |
| MSFT | Microsoft Corporation | Technology | Software - Infrastructure | 4.02% |
| PYPL | PayPal Holdings Inc | Financial Services | Credit Services | 3.99% |
| CSCO | Cisco Systems Inc | Technology | Communication Equipment | 3.92% |
| ACN | Accenture plc | Technology | Information Technology Services | 3.90% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.90% |
| LVS | Las Vegas Sands Corp | Consumer Cyclical | Resorts & Casinos | 3.76% |
| CMCSA | Comcast Corp | Communication Services | Telecom Services | 3.60% |
| ASML | ASML Holding NV ADR | Technology | Semiconductor Equipment & Materials | 3.50% |
| TXN | Texas Instruments Incorporated | Technology | Semiconductors | 3.45% |
| AMD | Advanced Micro Devices Inc | Technology | Semiconductors | 3.17% |
| ELV | Elevance Health Inc | Healthcare | Healthcare Plans | 3.13% |
| APD | Air Products and Chemicals Inc | Basic Materials | Specialty Chemicals | 3.13% |
| MCHP | Microchip Technology Inc | Technology | Semiconductors | 3.12% |
| APH | Amphenol Corporation | Technology | Electronic Components | 3.05% |
| CIEN | Ciena Corp | Technology | Communication Equipment | 3.01% |
| HON | Honeywell International Inc | Industrials | Conglomerates | 2.96% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 2.95% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 2.94% |